Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Calcium × 90 days × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 110 Carboplatin 108 Cisplatin 101 Paclitaxel 83 Gemcitabine 76 Specimen Handling 70 Magnetic Resonance Spectroscopy 67 Docetaxel 59 Dexamethasone 53 Capecitabine 53 Pemetrexed 52 Cyclophosphamide 52 Radiotherapy 50 Oxaliplatin 50 Doxorubicin 46 Bevacizumab 44 Rituximab 42 durvalumab 40 Radiation 40 Fluorouracil 40 Lenalidomide 37 Leucovorin 36 Vincristine 35 atezolizumab 31 Etoposide 28 130-nm albumin-bound paclitaxel 27 Prednisone 26 Letrozole 26 Irinotecan 26 Trastuzumab 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01480869 2026-03-12

VITACAL

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 3 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡